Progyny, Inc. (PGNY) Stock Analysis

Free AI-powered analysis and research for Progyny, Inc. stock

Sector: Healthcare

Analyze Progyny, Inc. (PGNY) Stock

Progyny, Inc. (PGNY) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into PGNY stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for Progyny, Inc. stock.

📰 Latest Update

Barclays Raises Hims & Hers (HIMS) Target to $29 After Novo Deal Clears Legal Overhang — Canaccord Cuts Progyny (PGNY) on Cautious 2026 Outlook

Wed, March 11, 2026 at 2:10 PM UTC 4 min read

Canaccord Genuity has downgraded Progyny (PGNY) due to a cautious outlook for 2026, raising concerns about the company's growth potential. This comes as Barclays increased its price target for Hims & Hers (HIMS) to $29 following the resolution of legal issues related to a deal with Novo. Investors should note that the downgrade may signal potential challenges for PGNY, impacting its stock performance in the near term.

Read full article →

Why Analyze Progyny, Inc. (PGNY) with StockIQ?

• ✅ Free AI-powered analysis of Progyny, Inc. (PGNY) stock
• ✅ Real-time technical indicators for Progyny, Inc. stock
• ✅ Comprehensive risk assessment for PGNY
• ✅ No credit card required

People also watch